Quick Answer
Medpace Holdings, Inc. reported Cash and Equivalents of $497.05 million for fiscal year 2025.
Medpace Holdings, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $497.05M | -25.8% |
| 2024 | $669.44M | +172.7% |
| 2023 | $245.45M | +768.4% |
| 2022 | $28.27M | -93.9% |
| 2021 | $461.30M | +66.1% |
| 2020 | $277.77M | +110.6% |
| 2019 | $131.92M | +466.8% |
| 2018 | $23.27M | -12.1% |
| 2017 | $26.48M | -28.6% |
| 2016 | $37.10M | +149.3% |
| 2015 | $14.88M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $285.35M | -56.6% | +515.9% |
| June 30, 2025 | $46.33M | -90.9% | -89.5% |
| March 31, 2025 | $441.44M | +8.5% | -34.1% |
| December 31, 2024 | $669.44M | +172.7% | +1.9% |
| September 30, 2024 | $656.90M | +590.0% | +28.6% |
| June 30, 2024 | $510.89M | +1205.4% | +25.5% |
| March 31, 2024 | $407.01M | +767.4% | +65.8% |
| December 31, 2023 | $245.45M | +768.4% | +157.8% |
- Medpace Holdings, Inc. showed a decrease of -25.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2015–2025 period, Medpace Holdings, Inc.’s cash and equivalents has grown by 3240.4% (from $14.88 million to $497.05 million).
- The most recent figure is from Medpace Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: